The DFNA5 gene was identified in 1998 as a gene that causes an autosomal dominant form of hearing impairment. Five different DFNA5 mutations have been found; each results in skipping of exon 8 at the messenger RNA level. This finding indicates that DFNA5-associated hearing loss is attributable to a highly specific gain-of-function mutation. Interestingly, later reports revealed that DFNA5 also plays a role in tumor biology.
Methods:
Recent data have shed more light on the biological function of DFNA5. Through a literature search, the current knowledge of this gene is reviewed.
Results:
DFNA5 is the first gene for monogenic deafness that is known to involve apoptosis as a disease mechanism — A mechanism that was shown to be involved in frequent types of hearing loss caused by age, noise, or drugs. In line with its apoptosis-inducing properties, DFNA5 is a tumor suppressor gene with an important role in major types of tumors.
Conclusions:
DFNA5 is a tumor suppressor gene that is involved in apoptosis pathways and as such performs a basic role in cell survival. In view of the known role of apoptosis in several forms of hearing loss, DFNA5 may be a player in the underlying disease mechanisms.
HuizingEHvan BolhuisAHOdenthalDW. Studies on progressive hereditary perceptive deafness in a family of 335 members. I. Genetical and general audiological results. Acta Otolaryngol1966;61:35–41.
2.
HuizingEHvan BolhuisAHOdenthalDW. Studies on progressive hereditary perceptive deafness in a family of 335 members. II. Characteristic pattern of hearing deterioration. Acta Otolaryngol1966;61:161–7.
3.
HuizingEHvan den WijngaartWSIMVerschuureJ. A follow-up study in a family with dominant progressive inner ear deafness. Acta Otolaryngol1983;95:620–6.
4.
van den WijngaartWSIMHuizingEHNiermeijerMFVerschuureJBrocaarMPBlomW. Follow-up study in a family with dominant progressive hereditary sensorineural hearing impairment. II. Clinical aspects. Audiology1985;24:336–42.
5.
van den WijngaartWSIMVerschuureJBrocaarMPHuizingEH. Follow-up study in a family with dominant progressive hereditary sensorineural hearing impairment. I. Analysis of hearing deterioration. Audiology1985;24:233–40.
6.
De LeenheerEMRvan ZuijlenDAVan LaerL. Further delineation of the DFNA5 phenotype: Results of speech recognition tests. Ann Otol Rhinol Laryngol2002;111:639–41.
7.
Van CampGCouckePBalemansW. Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum Mol Genet1995;4:2159–63.
8.
Van LaerLVan CampGvan ZuijlenD. Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. Eur J Hum Genet1997;5:397–405.
9.
Van LaerLHuizingEHVerstrekenM. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet1998;20:194–7.
10.
YuCMengXZhangSZhaoGHuLKongX. A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics2003;82:575–9.
11.
BischoffAMLCLuijendijkMWJHuygenPLM. A novel mutation identified in the DFNA5 gene in a Dutch family: A clinical and genetic evaluation. Audiol Neurootol2004;9:34–46.
12.
ChengJHanDYDaiP. A novel DFNA5 mutation, IVS8+4 AG, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family. Clin Genet2007;72:471–7.
13.
ParkHJChoHJBaekJI. Evidence for a founder mutation causing DFNA5 hearing loss in East Asians. J Hum Genet2010;55:59–62.
14.
Van LaerLDeStefanoALMyersRH. Is DFNA5 a susceptibility gene for age-related hearing impairment?. Eur J Hum Genet2002;10:883–6.
15.
SolomonNAWrightMBChangSBuckleyAMDumasLBGaberRF. Genetic and molecular analysis of DNA43 and DNA52: Two new cell-cycle genes in Saccharomyces cerevisiae. Yeast1992;8:273–89.
16.
GreganJVan LaerLLietoLDVan CampGKearseySE. A yeast model for the study of human DFNA5, a gene mutated in nonsyndromic hearing impairment. Biochim Biophys Acta2003;1638:179–86.
17.
DelmaghaniSdel CastilloFJMichelV. Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy. Nat Genet2006;38:770–8.
18.
CollinRWKalayEOostrikJ. Involvement of DFNB59 mutations in autosomal recessive nonsyndromic hearing impairment. Hum Mutat2007;28:718–23.
19.
ChaleshtoriM HashemzadehSimpsonMAFarrokhiE. Novel mutations in the pejvakin gene are associated with autosomal recessive non-syndromic hearing loss in Iranian families. Clin Genet2007;72:261–3.
20.
SchwanderMSczanieckaAGrilletN. A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function. J Neurosci2007;27:2163–75.
21.
EbermannIWalgerMSchollHP. Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction. Hum Mutat2007;28:571–7.
22.
ShahinHWalshTRayyanAA. Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families. Eur J Hum Genet2010;18:407–13.
23.
BorckGRainshteinLHellman-AharonyS. High frequency of autosomal-recessive DFNB59 hearing loss in an isolated Arab population in Israel. Clin Genet2011 Jun 23 [Epub ahead of print].
24.
SaekiNKuwaharaYSasakiHSatohHShiroishiT. Gasdermin (Gsdm) localizing to mouse Chromosome 11 is predominantly expressed in upper gastrointestinal tract but significantly suppressed in human gastric cancer cells. Mamm Genome2000;11:718–24.
25.
TamuraMTanakaSFujiiT. Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. Genomics2007;89:618–29.
26.
ChenEEkkerSC. Zebrafish as a genomics research model. Curr Pharm Biotechnol2004;5:409–13.
27.
Busch-NentwichESöllnerCRoehlHNicolsonT. The deafness gene dfna5 is crucial for ugdh expression and HA production in the developing ear in zebrafish. Development2004;131:943–51.
28.
NeuhaussSCSolnica-KrezelLSchierAF. Mutations affecting craniofacial development in zebrafish. Development1996;123:357–67.
29.
Van LaerLPfisterMThysS. Mice lacking Dfna5 show a diverging number of cochlear fourth row outer hair cells. Neurobiol Dis2005;19:386–99.
30.
LimDJAnnikoM. Developmental morphology of the mouse inner ear. A scanning electron microscopic observation. Acta OtolaryngolSuppl1985;422:1–69.
31.
Op de BeeckKVan CampGThysS. The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein. Eur J Hum Genet2011;19:965–73.
32.
Van LaerLVrijensKThysS. DFNA5: Hearing impairment exon instead of hearing impairment gene?. J Med Genet2004;41:401–6.
33.
Van LaerLMeyerNCMalekpourM. A novel DFNA5 mutation does not cause hearing loss in an Iranian family. J Hum Genet2007;52:549–52.
34.
DunøMHoveHKirchhoffMDevriendtKSchwartzM. Mapping genomic deletions down to the base: A quantitative copy number scanning approach used to characterise and clone the breakpoints of a recurrent 7p14.2p15.3 deletion. Hum Genet2004;115:459–67.
35.
ThompsonDAWeigelRJ. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur J Biochem1998;252:169–77.
36.
RassKHasselJC. Chemotherapeutics, chemoresistance and the management of melanoma. G Ital Dermatol Venereol2009;144:61–78.
37.
GrottkeCMantwillKDietelMSchadendorfDLageH. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int J Cancer2000;88:535–46.
38.
LageHHelmbachHGrottkeCDietelMSchadendorfD. DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells. FEBS Lett2001;494:54–9.
39.
MasudaYFutamuraMKaminoH. The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage. J Hum Genet2006;51:652–64.
40.
FujikaneTNishikawaNToyotaM. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat2010;122:699–710.
41.
JonesPABaylinSB. The fundamental role of epigenetic events in cancer. Nat Rev Genet2002;3:415–28.
42.
AkinoKToyotaMSuzukiH. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer. Cancer Sci2007;98:88–95.
43.
KimMSChangXYamashitaK. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene2008;27:3624–34.
44.
KimMSLebronCNagpalJK. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer. Biochem Biophys Res Commun2008;370:38–43.
45.
VrijensKVan CampGVan LaerL. Characterization of the murine Dfna5 promoter and regulatory regions. Gene2009;432:82–90.
46.
MuellerJCLõhmussaarEMägiR. Linkage disequilibrium patterns and tagSNP transferability among European populations. Am J Hum Genet2005;76:387–98.
47.
HagiwaraKNagaiHLiYOhashiHHottaTSaitoH. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma. J Clin Exp Hematop2007;47:15–8.
48.
NakagawaTYamaneHTakayamaMSunamiKNakaiY. Apoptosis of guinea pig cochlear hair cells following chronic aminoglycoside treatment. Eur Arch Otorhinolaryngol1998;255:127–31.
49.
ShaSHChenFQSchachtJ. Activation of cell death pathways in the inner ear of the aging CBA/J mouse. Hear Res2009;254:92–9.
50.
HuBHGuoWWangPYHendersonDJiangSC. Intense noise-induced apoptosis in hair cells of guinea pig cochleae. Acta Otolaryngol2000;120:19–24.
51.
WalshTPierceSBLenzDR. Genomic duplication and overexpression of TJP2/ZO-2 leads to altered expression of apoptosis genes in progressive nonsyndromic hearing loss DFNA51. Am J Hum Genet2010;87:101–9.
52.
AhmedZMYousafRLeeBC. Functional null mutations of MSRB3 encoding methionine sulfoxide reductase are associated with human deafness DFNB74. Am J Hum Genet2011;88:19–29.
